BenQ Medical Technology (ROCO:4116) Cyclically Adjusted Book per Share: NT$28.17 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4116 BenQ Medical Technology Corp ROCO:4116
81 GF Score
Price NT$38.60
GF Value NT$62.38
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is BenQ Medical Technology Cyclically Adjusted Book per Share?

BenQ Medical Technology ROCO:4116 +0.39% 81 Cyclically Adjusted Book per Share is NT$28.17 as of Dec. 2025. GuruFocus rates ROCO:4116 with a GF Score™ of 81/100 and a GF Value™ of NT$62.38 (Significantly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

BenQ Medical Technology's adjusted book value per share for the three months ended in Dec. 2025 was NT$25.281. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$28.17 for the trailing ten years ended in Dec. 2025.

During the past 12 months, BenQ Medical Technology's average Cyclically Adjusted Book Growth Rate was 1.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of BenQ Medical Technology was 3.90% per year. The lowest was 3.90% per year. And the median was 3.90% per year.

As of today (2026-07-17), BenQ Medical Technology's current stock price is NT$38.60. BenQ Medical Technology's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was NT$28.17. BenQ Medical Technology's Cyclically Adjusted PB Ratio of today is 1.37.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BenQ Medical Technology was 3.59. The lowest was 1.32. And the median was 2.02.


BenQ Medical Technology  (ROCO:4116) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BenQ Medical Technology's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=38.60/28.17
=1.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BenQ Medical Technology was 3.59. The lowest was 1.32. And the median was 2.02.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


BenQ Medical Technology Cyclically Adjusted Book per Share Related Terms


BenQ Medical Technology Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for BenQ Medical Technology's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BenQ Medical Technology Cyclically Adjusted Book per Share Chart

BenQ Medical Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 25.14 26.72 27.73 28.17

BenQ Medical Technology Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.73 28.00 28.21 28.39 28.17

ROCO:4116 vs ISRG, BDX, MDLN: Cyclically Adjusted Book per Share Comparison

For the Medical Instruments & Supplies subindustry, BenQ Medical Technology's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BenQ Medical Technology Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BenQ Medical Technology's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BenQ Medical Technology's Cyclically Adjusted PB Ratio falls into.


ROCO:4116
81GF Score
BenQ Medical Technology Corp ROCO:4116
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BenQ Medical Technology Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BenQ Medical Technology's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=25.281/324.0540*324.0540
=25.281

Current CPI (Dec. 2025) = 324.0540.

BenQ Medical Technology Quarterly Data

Book Value per Share CPI Adj_Book
201603 23.276 238.132 31.674
201606 22.062 241.018 29.663
201609 22.247 241.428 29.861
201612 22.541 241.432 30.255
201703 22.552 243.801 29.976
201706 22.270 244.955 29.461
201709 22.396 246.819 29.404
201712 22.821 246.524 29.998
201803 22.943 249.554 29.792
201806 22.302 251.989 28.680
201809 22.641 252.439 29.064
201812 23.263 251.233 30.006
201903 23.734 254.202 30.256
201906 22.638 256.143 28.640
201909 23.044 256.759 29.084
201912 23.566 256.974 29.718
202003 23.732 258.115 29.795
202006 22.555 257.797 28.352
202009 22.890 260.280 28.499
202012 23.650 260.474 29.423
202103 23.763 264.877 29.072
202106 22.832 271.696 27.232
202109 23.019 274.310 27.193
202112 23.293 278.802 27.074
202203 24.798 287.504 27.951
202206 25.567 296.311 27.961
202209 26.355 296.808 28.774
202212 33.479 296.797 36.554
202303 25.314 301.836 27.177
202306 25.670 305.109 27.264
202309 23.914 307.789 25.178
202312 24.679 306.746 26.072
202403 23.216 312.332 24.087
202406 23.886 314.175 24.637
202409 24.637 315.301 25.321
202412 25.177 315.605 25.851
202503 24.081 319.799 24.401
202506 23.673 322.561 23.783
202509 24.476 324.800 24.420
202512 25.281 324.054 25.281

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$28.17 mean?
BenQ Medical Technology (ROCO:4116) has a Cyclically Adjusted Book per Share of NT$28.17 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on BenQ Medical Technology and its competitors.
Is BenQ Medical Technology's Cyclically Adjusted Book per Share too high?
BenQ Medical Technology's current Cyclically Adjusted Book per Share is NT$28.17. Overall, BenQ Medical Technology has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BenQ Medical Technology's Cyclically Adjusted Book per Share compare to ISRG and BDX?
BenQ Medical Technology's Cyclically Adjusted Book per Share of NT$28.17 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on BenQ Medical Technology and its competitors. BenQ Medical Technology's current Cyclically Adjusted Book per Share is NT$28.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BenQ Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, BenQ Medical Technology (ROCO:4116) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$62.38, compared to a current price of NT$38.60 — trading 38.1% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$28.17. BenQ Medical Technology's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For BenQ Medical Technology (ROCO:4116), the current Cyclically Adjusted Book per Share is NT$28.17 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BenQ Medical Technology (ROCO:4116) Overvalued in 2026?

Based on GuruFocus' analysis, BenQ Medical Technology stock appears to be undervalued. The current stock price of NT$38.60 is trading 38.1% below its estimated GF Value™ of NT$62.38. GuruFocus considers BenQ Medical Technology to be Significantly Undervalued.

Key valuation signals for ROCO:4116:

  • Cyclically Adjusted Book per Share: NT$28.17
  • GF Value™: NT$62.38 vs. price of NT$38.60 (38.1% below fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the ROCO:4116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BenQ Medical Technology Business Description

Address No.46, Zhouzi Street, 7th Floor, Neihu District, Taipei, TWN, 11493
BenQ Medical Technology Corp is engaged in the manufacturing, assembly, maintenance, repair, and sales of professional medical equipment and consumables. Its products include surgical and gynecology tables, digital OR solutions, halogen and LED surgical lights, and medical imaging products, among others. The company's segment includes the R&D and Manufacturing Division and the Medical Services Division. The company generates the majority of its revenue from the Medical Services Division. Geographically, the company generates revenue from Taiwan, Mainland China, Indonesia, Thai, India, Colombia, and Others.
81GF Score

Get the complete analysis for ROCO:4116

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$38.60
Price
NT$62.38
GF Value